Researchers managed to reduce chronic inflammation associated with multiple sclerosis in mice thanks to the administration of a type of lipid that mediates inflammation. A team led by the Institut de ...

Clinicians and researchers have suspected for years that an aggressive, less-common form of multiple sclerosis (MS) is likely a distinct form of the disease. Now, new research conducted using a more ...

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in mice, the biotech announced Dec. 23. The Texas-based company conducted the ...

Please provide your email address to receive an email when new articles are posted on . The model predicted MS diagnosis with 91.5% specificity and non-MS diagnosis with 100% specificity. However, it ...

Researchers identify enzymes ceramide synthase 5 and 6 as key players in how saturated fats worsen multiple sclerosis symptoms. Study: Neuroprotective effect of neuron-specific deletion of the C16 ...

Researchers found that glatiramer acetate, a prescription drug currently used to treat patients with multiple sclerosis, improved memory in a mouse model of Alzheimer's disease. Losing memory is a ...

To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three ...